HIGH-DOSE STATIN PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION REDUCES OXIDATIVE STRESS BURDEN IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION
DOI:
https://doi.org/10.24193/subbchem.2019.1.11Keywords:
oxidative stress, acute myocardial infarction, statin, glutathione, percutaneous coronary interventionAbstract
The current study analysed the effect of high-dose statin loading prior to primary percutaneous coronary intervention on oxidative stress markers, in patients with acute ST-elevation myocardial infarction (STEMI). Besides the lipid lowering effect, statins have antioxidant properties that might reduce myocardial ischemia-reperfusion injury. From a total of 37 patients, 18 patients received high-dose statin before coronarography and were included in the statin group, while 19 statin naive patients were included in the control group. Peripheral venous blood samples were obtained before coronary reperfusion, at 1 hour and 24 hours after that. The following markers of oxidative stress were determined from the serum: malondialdehyde (MDA), reduced glutathione to oxidized glutathione ratio (GSH/GSSG) and total antioxidant capacity (TAC). Values are shown as medians and interquartile ranges. MDA concentration and TAC had non-significant differences between the two groups, at all time frames. Before angioplasty, GSH/GSSG ratio was comparable between the two groups: 3.59 (2.13-5.37) in the statin group vs 2.69 (2.15-5.02) in the control group, p=0.49. At 1 hour after reperfusion, values were still similar: 2.26 (1.32-4.28) in the statin group vs 2.33 (1.88-2.50) in the control group, p=0.55. After 24 hours, there was a significant increase of GSH/GSSG ratio in the statin group 2.41 (1.58-3.28) vs 1.56 (1.12-2.03) in the control group, p=0.01. This finding suggest that, in STEMI patients, high-dose statin loading before primary percutaneous coronary intervention significantly reduces oxidative stress burden, early after administration.
References
D. Olinic, M. Spinu, M. Olinic, C. Homorodean, D. Tataru, A. Liew, G. Schernthaner, A. Stanek, G. Fowkes, M. Catalano, International Angiology, 2018, 37, 327.
B. Ibanez and the ESC Taskforce, European Heart Journal, 2017, 00, 1.
P.T. O’Gara and the American Heart Association Task Force on Practice Guidelines, Journal of American College of Cardiology, 2013, 61, e78.
D. Yellon, D. Hausenloy, New England Journal of Medicine, 2007, 357, 1121.
D. Tataru, D. Olinic, A. Urda, M. Olinic, R. Orasan, Studia UBB Chemia, 2018, 3, 117.
M. Spînu, D. Olinic, M. Olinic, C. Homorodean, Romanian Journal of Morphology and Embryology, 2018, 59, 469.
C. Homorodean, M. Ober, M. Olinic, R. Homorodean, A. Hassoune, D. Tătaru, M. Spînu, D. Olinic, Medical Ultrasonography, 2016, 18, 475.
Violi, R. Carnevale, D. Pastori, P. Pignatelli, Trends in Cardiovascular Medicine, 2014, 24, 142.
O. Berwanger and the SECURE-PCI Study Group, JAMA, 2018, 319, 1331.
C. Wang, P. Liu, J. Liao, Trends in Molecular Medicine, 2008, 14, 37.
Y. Chai, S. Ashraf, K. Rokutan, R. Johnston, J. Thomas, Archives of Biochemistry and Biophysics, 1994, 310, 273.
B. Owen, D.A. Butterfield, Methods in Molecular Biology, 2010, 648, 269.
D.M. Mitrea, S. Clichici, A. Filip, D. Olteanu, I. Baldea, R. Moldovan, N. Decea, O.A. Hoteiuc, Studia UBB Chemia, 2017, 62, 89.
E. Sedláková, O. Rácz, E. Lovásová, R. Beňačka, M. Kurpas, A. Chmelárová, J. Sedlák, M. Studenčan, Central European Journal of Medicine, 2009, 4, 26.
Coneac, M.S. Orasan, M. Crisan, C. Mare, N. Decea, C.M. Mihu, A. Muresan, V. Lazar, M. Filip, Studia UBB Chemia, 2016, 2, 177.
Moldovan, L. David, S.C. Man, Studia UBB Chemia, 2017, 2, 311.
Simon, D. Simedru, L. Dordai, E. Luca, V. Fuss, A. Becze, Studia UBB Chemia, 2016, 61, 505.
S.B. Kedare, R.P. Singh, Journal of Food Science and Technology, 2011, 48, 412.
K. Olsson, J. Harnek, A. Ohlin A, N. Pavlidis, B. Thorvinger, H. Ohlin, Scandinavian Cardiovascular Journal, 2002, 36, 237.
P.M. Ridker and the CANTOS Trial Group, New England Journal of Medicine, 2017, 12, 1119.
A.J. Lansky, G.W. Stone, Circulation: Cardiovascular Interventions, 2010, 3, 602.
G.J. Moon, S.J. Kim, Y. Cho, S. Ryoo, O. Bang, Journal of Clinical Neurology, 2014, 10, 140.
M. Yilmaz, Y. Baykal, M. Kilic, A. Sonmez, F. Bulucu, A. Aydin, A. Sayal, I. Kocar, Biological Trace Element Research, 2004, 2, 119.
P.G. Scheffer, R.K. Schindhelm, V.M. van Verschuer, M. Groenemeijer, S. Simsek, Y. Smulders, P. Nanayakka, The Netherlands Journal of Medicine, 2013, 7, 359.
I. Khalaf, L. Vlase, B. Ivanescu, D. Lazar, A. Corciova, Studia UBB Chemia, 2012, 2, 113.
D. Benedec, I.E. Popica, I. Oniga, D. Hanganu, M. Duma, R. Silaghi-Dumitrescu, C. Bischin, l. Vlase, Studia UBB Chemia, 2015, 4, 257.
A. Dragus, M.S. Beldean-Galea, Studia UBB Chemia, 2015, 2, 117.
A. Ceconi, A. Cargoni, E. Pasini, E. Condorelli, S. Curello, R. Ferrari, American Journal of Physiology - Heart and Circulatory Physiology, 1991, 260, H1057.
H. Buyukhatipoglu, Y. Suzun, A. Yildiz, U. Guntekin, M. Bas, M. Polat, R. Demirbag, A. Taksin, H. Celik, N. Aksoy, Clinical and Investigative Medicine, 2010, 5, E313.
World Medical Association, Journal of the American Medical Association, 2013, 310, 2191.
D. Olinic, D. Tataru, C. Homorodean, M. Spinu, M. Olinic, Vasa, 2018, 47, 99.
D. Olinic, S. Nedevschi, C. Feier, Z. Gal, N. Olinic, Computers in Cardiology, 1999, 443.
C. Homorodean, M. Olinic, D.M. Olinic, Medical Ultrasonography, 2012, 14, 29.
M. Conti, P.C. Morand, P. Levillain, A. Lemonnier, Clinical Chemistry, 1991, 37, 1273.
M.L. Hu, Methods in Enzymology, 1994, 233, 380.
P. Vats, V.K. Singh, S.S. Sing, Aviation, Space and Environmental Medicine, 2008, 79, 1106.
A. Janaszewska, G. Bartosz, Scandinavian Journal of Clinical and Laboratory Investigation, 2002, 62, 231.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Studia Universitatis Babeș-Bolyai Chemia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
